Daniel Loeb

Daniel Loeb

Last Update: 2014-03-13

Number of Stocks: 45
Number of New Stocks: 16

Total Value: $5,802 Mil
Q/Q Turnover: 40%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb' s Profile & Performance

Profile

Daniel Seth Loeb is founder of Third Point LLC, a New York based hedge fund managing over $2.3 billion in assets. Loeb is well known in the financial world for writing public letters in which he expresses disapproval of the performance and conduct of other financial executives.

Web Page:http://www.thirdpointpublic.com/

Total Holding History

Performance of Master Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
201325.231.55-6.3
201221.215.45.8
2011-0.12.08-2.2
3-Year Cumulative51.6 (14.9%/year)55 (15.7%/year)-3.4 (-0.8%/year)
201033.515.0618.4
200938.226.4611.7
5-Year Cumulative179.7 (22.8%/year)125.5 (17.7%/year)54.2 (5.1%/year)
2008-32.8-374.2
200716.65.6111.0
20061515.79-0.8
200519.94.9115.0
200430.21218.2
10-Year Cumulative293.4 (14.7%/year)104.1 (7.4%/year)189.3 (7.3%/year)
200351.528.722.8
2002-7-22.115.1
200114.9-11.926.8
200017.1-9.126.2
199942.22121.2
15-Year Cumulative960.5 (17%/year)98.3 (4.7%/year)862.2 (12.3%/year)
19986.628.6-22.0
199752.133.418.7
199644.32321.3
19953737.6-0.6

Top Ranked Articles

Market Cycle Analysis & Five-Year Rolling Analysis of Guru Performance
Market Cycle Analysis In our research of John Hussman’s performance, we observed that he underperformed the market if we look at the latest 3-year annualized return, 5-year annualized return and even 10-year annualized return. Yet this might not be the case if we look at his performance over a complete economic cycle. Read more...
Dan Loeb’s Letter to the Board of Yahoo
LETTER TO THE BOARD OF DIRECTORS OF THE ISSUER Read more...
Talks of Carl Icahn Getting a Piece of Herbalife, Joining Loeb in Long Position
After fellow activist investor, Daniel Loeb set off the media earlier this week with his declaration to obtain a long position in Herbalife (HLF), a company that Pershing Square’s Bill Ackman just shorted weeks ago, corporate raiding Guru Carl Icahn has been reported yesterday afternoon of joining Loeb in taking a piece of the action. Read more...
Daniel Loeb Comments on AIG
Equity: AIG (AIG) Read more...
Why Third Point Capital's Daniel Loeb Is Beating John Paulson and David Einhorn
On Wednesday, Reuters reported that hedge funds overall have lost an average of 2% over the first half of the year, while the S&P gained around 6%. Below the average are unexpected names like John Paulson (flagship fund down 15%), David Einhorn (Greenlight Capital down 5%), and Bill Ackman (Pershing Square Capital down 2.27%). Read more...
» More Daniel Loeb Articles

Commentaries and Stories

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Global Market Valuations and Expected Returns – April 4, 2014 Daniel Loeb,Francis Chou - Global Market Valuations And Expected Returns – April 4, 2014
In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after an excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. The market benchmark S&P 500 closed at 1890.90 on April 2, 2014, which is the new record high. What is the situation in the other parts of the world? In March, the key indexes in Europe returned negative. Germany’s DAX index declined 1.40%. France’s CAC-40 index lost 0.38%. The FTSE 100 index was down 3.10%. Stock market performances in Asia were weak too. Japan’s NIKKEI 225 moderately decreased 0.09%. Hong Kong’s Hang Seng Index was down 3.00% and China’s SSE Composite index was down 1.12% due to the weaker-than-expected Chinese economic data. More...

  • Currently 5.00/5

Rating: 5.0/5 (3 votes)

Big Solutions to Improve Dow's Balance Sheet
The Dow Chemical Company (DOW) is the largest U.S. chemical maker by sales. It is engaged in manufacturing and supplying products used primarily as raw materials in the manufacture of customer products and services. The company serves the following industries: appliance; automotive; agricultural; building and construction; chemical processing; electronics; furniture; housewares; oil and gas; packaging; paints, coatings and adhesives; personal care; pharmaceutical; processed foods; pulp and paper; textile and carpet; utilities; and water treatment. More...

LONG, CHEMICALS


  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Diversification, Hedging and Joint-Ventures Are Cabot´s Long-Term Drivers
Cabot Oil & Gas Corp. (COG) is an oil and gas company engaged in the development, exploitation, exploration, production and marketing of natural gas, crude oil and, to a lesser extent, natural gas liquids. The company also transports, stores, gathers and purchases natural gas for resale. More...

LONG, ENERGY, OIL, GAS


  • Currently 5.00/5

Rating: 5.0/5 (4 votes)

Absolute and Relative Valuation Models Indicate the Same: Abbot Is a Buy Daniel Loeb,Jim Simons - Absolute And Relative Valuation Models Indicate The Same: Abbot Is A Buy
Abbott Laboratories (ABT) is engaged in the discovery, development, manufacture and sale of health care products. Market-based metrics indicate that the stock is relatively undervalued. So now let's take a look at the intrinsic value of this company and try to explain to investors the reasons why it is a good buy or not. With a dividend-payment history that affirms its commitment to maximize shareholder wealth, the company raised its quarterly dividend by 57% to $0.22 per share from $0.14. Its dividend yield is 1.67%, ahead of the industry yield of 1.35%. This makes it interesting to analyze the Discount Dividend Model. More...

LONG, HEALTH, CARE


  • Currently 3.00/5

Rating: 3.0/5 (2 votes)

Is Liberty Global Speeding Up Too Quickly?
Liberty Global Plc (LBTYA)’s John Malone has a track record for purchasing small and medium-sized companies, with the goal of expanding the media and communications empire. The most recent example of this strategy was seen at the beginning of the month, when the company acquired the remaining 20% of Chile’s largest cable operator VTR for 10.1 million shares ($422 million). Furthermore, to guarantee the firm’s proper management and elevate the customer experience, VTR has entered Telecom Italy’s Global Partnership Program, which should help improve operational efficiency. However, while there is no doubt about Liberty’s growth prospects, many investment gurus like Eric Mindich (Trades, Portfolio) and Daniel Loeb (Trades, Portfolio) More...

MEDIA,COMMUNICATIONS,VTR,CABLE OPERATORS,TELEVISION,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Sotheby's Response to Third Point Litigation
NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) -- Sotheby's (BID) issued the following in response to reports that Third Point has filed litigation against the Company. More...

DANIEL LOEB


  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Abbott Capturing Incremental Market Share
Abbott Laboratories (ABT) is engaged in the discovery, development, manufacture, and sale of health care products. The company’s reportable segments include: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. Non-reportable segments include the Diabetes Care and Medical Optics segments. More...

LONG, HEALTHCARE, PHARMA


  • Currently 5.00/5

Rating: 5.0/5 (3 votes)

Activist Billionaire Daniel Loeb in a Battle for Control of Sotheby’s
Daniel Seth Loeb is founder of Third Point LLC, a New York-based hedge fund. On Feb. 27, he added Sotheby's (BID) at an average price of $50.51 and on March 11, he added the stock again at an average price of $47.27. He currently holds 6.65 million shares of the stock with a current value of $293 million in his portfolio and his stake in Sotheby's is about 9.6%. So let's take a look at this company and try to explain to investors the reasons why he is betting on it. More...

LONG, AUCTIONEER, AUCTION, DECORATIVE, ART, JEWELRY


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Sotheby's Open Letter to Shareholders Regarding Third Point’s Board Nominees
SOTHEBY’S SENDS OPEN LETTER TO SHAREHOLDERS More...

THIRD POINT, DANIEL LOEB


  • Currently 4.00/5

Rating: 4.0/5 (2 votes)

Global Market Valuations and Expected Returns – March 6, 2014 Daniel Loeb,Howard Marks - Global Market Valuations And Expected Returns – March 6, 2014
In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after an excellent 2013. The enthusiasm went back as the market gained 4.31% over February. The S&P 500 continuously hit new highs. What is the situation in the other parts of the world? In February, the key indexes in Europe surged. Germany’s DAX index increased 4.14%. France’s CAC-40 index gained 5.82%. The FTSE 100 index was up 4.60%. Stock markets performances in Asia were weak when compared with in Europe. Japan’s NIKKEI 225 moderately decreased 0.49%. Hong Kong’s Hang Seng Index gained 3.64% and China’s SSE Composite index was up 1.14%. More...

  • Currently 1.86/5

Rating: 1.9/5 (7 votes)

Daniel Loeb is Buying BlackBerry–Should You? Daniel Loeb - Daniel Loeb Is Buying BlackBerry–Should You?
BlackBerry (BBRY) has been a value trap that has ensnared more than its share of value hunting investors in recent years —yours truly included. Buying BlackBerry stock will also likely go down in history as the single-worst investing mistake in the otherwise illustrious career of Prem Watsa (Trades, Portfolio) — the chairman ofFairfax Financial (FRFHF) and the man commonly known as the “Warren Buffett of Canada.” More...

  • Currently 4.50/5

Rating: 4.5/5 (2 votes)

Global Market Valuations and Expected Returns – Feb. 6, 2014 Daniel Loeb,Howard Marks - Global Market Valuations And Expected Returns – Feb. 6, 2014
The U.S. stock market had an excellent 2013. The performance of all three major U.S. stock indexes was the best since the financial crisis in 2008. What is the situation in the other parts of the world? Among the key markets in Europe in 2013, Germany’s DAX index increased 25.48%. France’s CAC-40 index rose 17.99%. The FTSE 100 index went up 14.43%. Stock markets performances in Japan were strong. Japan’s NIKKEI 225 surged by 56.72%. Hong Kong’s Hang Seng Index was up only 2.87% and China’s SSE Composite index decreased 6.75%. More...

  • Currently 4.83/5

Rating: 4.8/5 (6 votes)

Loeb Has the Right Position and Waits for a Potential Merger
Activist investor Daniel Loeb (Trades, Portfolio) added T-Mobile US Inc. (TMUS) at a price of $25. It makes me feel that he is betting that the company could be acquired by Sprint Corp. (S) or Dish Network Corp. (DISH). So let's take a look at this company and try to explain to investors the reasons this is an apparently appealing investment opportunity. More...

LONG, TELECOM, CELL, COMMUNICATIONS, CARRIERS, T-MOBILE, LOEB, TMUS, S, DISH, VZ, T, CLWR, USM, TDS


  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Daniel Loeb Comments on Intrexon Corporation
Equity Position: Intrexon Corporation (XON) ("Intrexon") We initially invested in Intrexon in 2011 in a private round and have continued to accumulate shares since its IPO in August 2013. We believe that Intrexon is an innovation leader in synthetic biology with a unique value proposition and proven leadership team. Most attractive to us is Intrexon's potential to transform multiple industries, including the health, food, and energy markets.  More...

  • Currently 2.00/5

Rating: 2.0/5 (2 votes)

Daniel Loeb Comments on T-Mobile
T-Mobile (TMUS) – We had the opportunity to establish a position in T-Mobile in November when the Company conducted a secondary offering at $25. The offering represented a favorable relative valuation versus peers, enhanced by recently improved relative operating performance and an attractive EBITDA growth trajectory.  More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on Sony
Sony (SNE) – While the rejection of Third Point's proposal to partially list the Entertainment business proved costly for shareholders, we are hopeful that the Company's commitment to improve transparency, increase margins, better allocate capital among divisions, and hold division management accountable will lead to our goal: increasing shareholder value. Despite the rise in the Company share price earlier in the year, Sony shares still trade significantly below their sum of the parts valuation.  More...

  • Currently 3.00/5

Rating: 3.0/5 (4 votes)

Daniel Loeb Comments on Ally Financial
Third Point has invested across the capital structure of Ally Financial (ALFI), the former GMAC, throughout the company's multi-year reorganization. Today's Ally Financial ("Ally") fits the pattern of other profitable investments we have made: a highly successful, nearly-completed restructuring that remains undervalued, with an explosive earnings story led by a talented management team who are economically aligned with shareholders. More...

  • Currently 2.00/5

Rating: 2.0/5 (1 vote)

Daniel Loeb Comments on Dow Chemical Company
Third Point's largest current investment is in The Dow Chemical Company (DOW)("Dow"). Dow shares have woefully underperformed over the last decade, generating a return of 46% (including dividends) compared to a 199% return for the S&P 500 Chemicals Index and a 101% return for the S&P 500.1 Indeed, in April 1999, nearly 15 years ago, an investor could have purchased Dow shares for the same price that they trade at today! These results reflect a poor operational track record across multiple business segments, a history of under-delivering relative to management's guidance and expectations, and the ill-timed acquisition of Rohm & Haas. The company's weak performance is even more surprising given that the North American shale gas revolution has been a powerful tailwind for Dow's largest business exposure – petrochemicals.  More...

  • Currently 1.00/5

Rating: 1.0/5 (1 vote)

Daniel Loeb Third Point - Q4 2013 Investor Letter
  • Currently 4.75/5

Rating: 4.8/5 (4 votes)

Dan Loeb Takes an Active (and Large) Position in Dow Chemical - Urges Spin-Off

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide